中国临床新医学
中國臨床新醫學
중국림상신의학
CHINESE JOURNAL OF NEW CLINICAL MEDICINE
2014年
1期
1-4
,共4页
刘琼%黄昌杰%黄文锋%湛永滋%黄剑锋%王湘萍
劉瓊%黃昌傑%黃文鋒%湛永滋%黃劍鋒%王湘萍
류경%황창걸%황문봉%담영자%황검봉%왕상평
非小细胞肺癌%肺耐药蛋白%顺铂%耐药%预后
非小細胞肺癌%肺耐藥蛋白%順鉑%耐藥%預後
비소세포폐암%폐내약단백%순박%내약%예후
Non-small cell Lung Cancer ( NSCLC)%Lung resistance protein ( LRP)%Platinum%Drug resistanc%Prognosis
目的探讨晚期非小细胞肺癌(NSCLC)组织中肺耐药蛋白(LRP)的表达与铂类化疗耐药及其预后的关系。方法采用免疫组织化学SP法对89例晚期NSCLC碏块进行免疫组织化学染色,检测LRP的表达水平,并分析其与患者的性别、年龄、吸烟史、组织分型、分化程度、远处转移、淋巴结转移及含铂化疗方案疗效的关系。结果在NSCLC患者组织中,LRP的阳性表达率为77.5%,与年龄、吸烟史、组织分型、分化程度和淋巴结转移无关( P均>0.05),而LRP表达阳性组和阴性组的含铂类方案化疗疗效、有效率、总反应率、无进展生存时间和总生存时间比较差异无统计学意义( P均>0.05)。女性患者肿瘤组织LRP表达阳性率(95.5%)高于男性患者(71.6%)(P=0.043);在远处转移的患者中,LPR阳性表达率为87.3%,而无远处转移的患者LRP阳性表达率为61.8%,差异有统计学意义( P=0.005)。结论 LRP基因的阳性表达与远处转移有关,且LRP阳性表达患者无疾病进展时间及总生存时间均低于LRP阴性表达患者,提示其可能作为判断预后指标。
目的探討晚期非小細胞肺癌(NSCLC)組織中肺耐藥蛋白(LRP)的錶達與鉑類化療耐藥及其預後的關繫。方法採用免疫組織化學SP法對89例晚期NSCLC碏塊進行免疫組織化學染色,檢測LRP的錶達水平,併分析其與患者的性彆、年齡、吸煙史、組織分型、分化程度、遠處轉移、淋巴結轉移及含鉑化療方案療效的關繫。結果在NSCLC患者組織中,LRP的暘性錶達率為77.5%,與年齡、吸煙史、組織分型、分化程度和淋巴結轉移無關( P均>0.05),而LRP錶達暘性組和陰性組的含鉑類方案化療療效、有效率、總反應率、無進展生存時間和總生存時間比較差異無統計學意義( P均>0.05)。女性患者腫瘤組織LRP錶達暘性率(95.5%)高于男性患者(71.6%)(P=0.043);在遠處轉移的患者中,LPR暘性錶達率為87.3%,而無遠處轉移的患者LRP暘性錶達率為61.8%,差異有統計學意義( P=0.005)。結論 LRP基因的暘性錶達與遠處轉移有關,且LRP暘性錶達患者無疾病進展時間及總生存時間均低于LRP陰性錶達患者,提示其可能作為判斷預後指標。
목적탐토만기비소세포폐암(NSCLC)조직중폐내약단백(LRP)적표체여박류화료내약급기예후적관계。방법채용면역조직화학SP법대89례만기NSCLC작괴진행면역조직화학염색,검측LRP적표체수평,병분석기여환자적성별、년령、흡연사、조직분형、분화정도、원처전이、림파결전이급함박화료방안료효적관계。결과재NSCLC환자조직중,LRP적양성표체솔위77.5%,여년령、흡연사、조직분형、분화정도화림파결전이무관( P균>0.05),이LRP표체양성조화음성조적함박류방안화료료효、유효솔、총반응솔、무진전생존시간화총생존시간비교차이무통계학의의( P균>0.05)。녀성환자종류조직LRP표체양성솔(95.5%)고우남성환자(71.6%)(P=0.043);재원처전이적환자중,LPR양성표체솔위87.3%,이무원처전이적환자LRP양성표체솔위61.8%,차이유통계학의의( P=0.005)。결론 LRP기인적양성표체여원처전이유관,차LRP양성표체환자무질병진전시간급총생존시간균저우LRP음성표체환자,제시기가능작위판단예후지표。
Objective To study the expression of lung resistance protein (LRP) in non-small cell Lung Cancer(NSCLC) and its correlation with Platium resistance and prognosis .Methods The expression of LRP in 89 NSCLC patients was detected by the way of immunohistochemical method .The relationship between LRP and clinico-pathological feature and the others (age, sex, smoking history, histological type, differentiation, distant metastasis, lymphatic metastasis and so on ) were studied .Results In the tissues of patients with NSCLC , the positive express-ing rate of LRP was 77.5%, and was not related with age , sex, smoking history, histological type, differentiation, distant metastasis , lymphatic metastasis ( P>0.05 ) .In the platinum contained chemotherapy regimens , there were not statistical significant difference in RR , DCR, PFS, and OS between the LRP positive expression group and the LRP negative expression group ( all P>0.05 ) .The positive expression rate of LRP in female patients ( 95.5%) was higher than that in male patients(71.6%;P=0.043).The positive expression rate in the patient with distant metas-tasis(87.3%) was higher than that in the patients without distant metastasis (61.8%)(P=0.005).Conclusion The positive expression of LRP is related to the diagnosis distant metastasis of NSCLC .The PFS, OS in LRP-positive patients are lower than those in LRP negative patients .These results suggest LRP may be an evaluating indicator of the prognosis of NSCLC .